Advestra advises Novartis on all Swiss aspects of its USD 11.0 billion notes

Novartis successfully placed notes in the aggregate principal amount of USD 11.0 billion in seven tranches of which six were fixed rate notes while one tranche were floating rate notes. The notes were issued by Novartis Capital Corporation and guaranteed by Novartis AG.

The proceeds will be used to refinance the acquisition of Avidity Biosciences, Inc.  

Advestra acted as Swiss legal counsel to Novartis. The team included Annette Weber, Thomas Reutter and Valérie Bayard (all Capital Markets) as well as Céline Martin (Tax).